MPEP § 2412.02(a) — “Enumeration of its residues” (Annotated Rules)
§2412.02(a) “Enumeration of its residues”
This page consolidates and annotates all enforceable requirements under MPEP § 2412.02(a), including statutory authority, regulatory rules, examiner guidance, and practice notes. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.
“Enumeration of its residues”
This section addresses “Enumeration of its residues”.
Key Rules
Sequence Listing Content
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
(d) “Enumeration of its residues” means disclosure of a nucleotide or amino acid sequence in a patent application by listing, in order, each residue of the sequence, where the residues are represented in the manner as defined in paragraph 3(c)(i) or (ii) of WIPO Standard ST.26 (incorporated by reference, see § 1.839).
Citations
| Primary topic | Citation |
|---|---|
| Sequence Listing Content | 37 CFR § 1.831(b) |
| Sequence Listing Content | 37 CFR § 1.839 |
Source Text from USPTO’s MPEP
This is an exact copy of the MPEP from the USPTO. It is here for your reference to see the section in context.
Official MPEP § 2412.02(a) — “Enumeration of its residues”
Source: USPTO2412.02(a) “Enumeration of its residues” [R-01.2024]
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
37 CFR 1.831 Requirements for patent applications filed on or after July 1, 2022, having nucleotide and/or amino acid sequence disclosures.
-
*****
- (d) “Enumeration of its residues” means disclosure of a nucleotide or amino acid sequence in a patent application by listing, in order, each residue of the sequence, where the residues are represented in the manner as defined in paragraph 3(c)(i) or (ii) of WIPO Standard ST.26 (incorporated by reference, see § 1.839).
-
*****
WIPO Standard ST.26 specifies that “enumeration of its residues” means “disclosure of a sequence in a patent application by listing, in order, each residue of the sequence, wherein either (i) the residue is represented by a name, abbreviation, symbol, or structure (e.g., HHHHHHQ or HisHisHisHisHisHisGln); or (ii) multiple residues are represented by a shorthand formula (e.g., His6Gln) (WIPO Standard ST.26, paragraph 3(c)). See also the Guidance portion of the Standard, Annex VI, page 3.26.vi.2 for a discussion of “enumeration of its residues” and page 3.26.vi.18-19, 51, 53 for examples.